MERLION ANNOUNCES COLLABORATIVE RESEARCH AGREEMENT WITH THE NATIONAL CANCER INSTITUTE

MerLion Pharmaceuticals Pte Ltd, a Singapore-based drug discovery company today announced the establishment of a research collaboration with the National Cancer Institute (NCI) of the USA. The overall goal of this agreement is the discovery and development of novel small molecule inhibitors of the hypoxic signaling pathway from MerLion's proprietary library of natural products.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/86ccac835509353d7b7f3f962c39534b.html)